Back to Search Start Over

Lenalidomide plus dexamethasone for high-risk smoldering multiple myeloma

Authors :
Mateos MV
Hernández MT
Giraldo P
de la Rubia J
de Arriba F
López Corral L
Rosiñol L
Paiva B
Palomera L
Bargay J
Oriol A
Prosper F
López J
Olavarría E
Quintana N
García JL
Bladé J
Lahuerta JJ
San Miguel JF
Source :
NEW ENGLAND JOURNAL OF MEDICINE, r-IIS La Fe. Repositorio Institucional de Producción Científica del Instituto de Investigación Sanitaria La Fe, instname
Publication Year :
2013
Publisher :
MASSACHUSETTS MEDICAL SOC, 2013.

Abstract

For patients with smoldering multiple myeloma, the standard of care is observation until symptoms develop. However, this approach does not identify high-risk patients who may benefit from early intervention.

Subjects

Subjects :
hemic and lymphatic diseases

Details

ISSN :
00284793
Database :
OpenAIRE
Journal :
NEW ENGLAND JOURNAL OF MEDICINE, r-IIS La Fe. Repositorio Institucional de Producción Científica del Instituto de Investigación Sanitaria La Fe, instname
Accession number :
edsair.RECOLECTA.....282e9f4ad7a081541ecc800ce9220893